Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Status: Enrolling
Updated:  12/31/1969
1734
mi
from 98109
Chicago, IL
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Characterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour Period
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
1734
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2337
mi
from 98109
Chapel Hill, NC
The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Food Effect and CYP1A2 Induction Study in Healthy Subjects
Hase I Open-Label Two-Part Study To Evaluate The Effect Of Food and Of CYP1A2 Induction On Pomalidomide (CC-4047) Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
2529
mi
from 98109
Daytona Beach, FL
Food Effect and CYP1A2 Induction Study in Healthy Subjects
Hase I Open-Label Two-Part Study To Evaluate The Effect Of Food and Of CYP1A2 Induction On Pomalidomide (CC-4047) Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit, Inc.
2529
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Status: Enrolling
Updated:  12/31/1969
1734
mi
from 98109
Chicago, IL
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
1734
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
2432
mi
from 98109
New Haven, CT
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
New Haven Clinical Research Unit
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated:  12/31/1969
2401
mi
from 98109
New York, NY
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated: 12/31/1969
NYSPI
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Dietary Methionine and Cysteine Restriction in Healthy Adults
Dietary Methionine and Cysteine Restriction in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
2220
mi
from 98109
State College, PA
Dietary Methionine and Cysteine Restriction in Healthy Adults
Dietary Methionine and Cysteine Restriction in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
Penn State University
2220
mi
from 98109
State College, PA
Click here to add this to my saved trials
Emotion Study -- A Neurofeedback Approach
Emotion Study -- Improving Neural Dysregulation in Advanced Age: A Neurofeedback Approach
Status: Enrolling
Updated:  12/31/1969
2452
mi
from 98109
Gainesville, FL
Emotion Study -- A Neurofeedback Approach
Emotion Study -- Improving Neural Dysregulation in Advanced Age: A Neurofeedback Approach
Status: Enrolling
Updated: 12/31/1969
University of Florida
2452
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated:  12/31/1969
2366
mi
from 98109
Flourtown, PA
Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Primary Care, Flourtown, Children's Hospital of Philadelphia
2366
mi
from 98109
Flourtown, PA
Click here to add this to my saved trials
Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated:  12/31/1969
2370
mi
from 98109
Philadelphia, PA
Video to Promote HPV Vaccination
Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination
Status: Enrolling
Updated: 12/31/1969
Nicholas and Athena Karabots Pediatric Care Center
2370
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated:  12/31/1969
1937
mi
from 98109
Galveston, TX
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
UTMB Acute Care for Elders Unit
1937
mi
from 98109
Galveston, TX
Click here to add this to my saved trials
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated:  12/31/1969
1937
mi
from 98109
Galveston, TX
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults
Feasibility Study of Post-hospitalization Interventions to Improve Physical Function
Status: Enrolling
Updated: 12/31/1969
Jennie Sealy Hospital
1937
mi
from 98109
Galveston, TX
Click here to add this to my saved trials
The Effects of Hydromorphone on Responses to Verbal Tasks
The Effects of Hydromorphone on Responses to Verbal Tasks
Status: Enrolling
Updated:  12/31/1969
1737
mi
from 98109
Chicago, IL
The Effects of Hydromorphone on Responses to Verbal Tasks
The Effects of Hydromorphone on Responses to Verbal Tasks
Status: Enrolling
Updated: 12/31/1969
University of Chicago Hospital
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of LY2409021 in Healthy Participants
A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
2529
mi
from 98109
Daytona Beach, FL
A Study of LY2409021 in Healthy Participants
A Single Dose Pharmacokinetic Study of LY2409021 Tablet Administered in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2529
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
A Phase I Study of Modified Vaccinia Ankara With Mosaic HIV Inserts in Healthy, HIV-Uninfected Adults, Some of Whom Have Previously Received an Adenovirus Type 26 ENVA.01 Vaccine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated:  12/31/1969
2527
mi
from 98109
Tampa, FL
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated:  12/31/1969
2527
mi
from 98109
Tampa, FL
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
USF South Tampa Center
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated:  12/31/1969
2527
mi
from 98109
Tampa, FL
Predictors of Lactogenesis II
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
Status: Enrolling
Updated: 12/31/1969
TGH Health Park Genesis Clinic
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Status: Enrolling
Updated:  12/31/1969
2331
mi
from 98109
Baltimore, MD
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
Status: Enrolling
Updated: 12/31/1969
National Institute on Drug Abuse
2331
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate Pharmacokinetics of Apremilast in Heatlhy Male Subjects
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
1622
mi
from 98109
Madison, WI
Study to Evaluate Pharmacokinetics of Apremilast in Heatlhy Male Subjects
A Phase 1, Open-Label, Single Center Study to Evaluate the Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast (CC-10004) in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit
1622
mi
from 98109
Madison, WI
Click here to add this to my saved trials
A Study of LY3079514 in Healthy Participants
A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
955
mi
from 98109
Glendale, CA
A Study of LY3079514 in Healthy Participants
A Single-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3079514 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
California Clinical Trials Medical Group
955
mi
from 98109
Glendale, CA
Click here to add this to my saved trials
A Study of LY2835219 in Healthy Participants
Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
1682
mi
from 98109
Dallas, TX
A Study of LY2835219 in Healthy Participants
Effects of CYP3A Induction by Rifampin on the Pharmacokinetics of LY2835219 and Its Metabolites in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Status: Enrolling
Updated:  12/31/1969
1780
mi
from 98109
North Little Rock, AR
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
1780
mi
from 98109
North Little Rock, AR
Click here to add this to my saved trials
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
A Phase 1, Open-label, 2-Part Study to Evaluate the Bioequivalence of the Duvelisib Marker-Image Formulation to the Duvelisib Clinical-Trial Formulation and to Assess the Effect of Food on the Pharmacokinetics of IP Duvelisib in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
1502
mi
from 98109
Lenexa, KA
Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145
A Phase 1, Open-label, 2-Part Study to Evaluate the Bioequivalence of the Duvelisib Marker-Image Formulation to the Duvelisib Clinical-Trial Formulation and to Assess the Effect of Food on the Pharmacokinetics of IP Duvelisib in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1502
mi
from 98109
Lenexa, KA
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated:  12/31/1969
679
mi
from 98109
San Francisco, CA
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Southeast Asian Community Center (SEACC)
679
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated:  12/31/1969
934
mi
from 98109
San Francisco, CA
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Chinese Community Health Resource Center
934
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated:  12/31/1969
712
mi
from 98109
San Jose, CA
A Family-Focused Intervention for Asian American Male Smokers
A Family-Focused Intervention for Asian American Male Smokers
Status: Enrolling
Updated: 12/31/1969
Vietnamese Voluntary Foundation
712
mi
from 98109
San Jose, CA
Click here to add this to my saved trials
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Status: Enrolling
Updated:  12/31/1969
1503
mi
from 98109
Overland Park, KA
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1503
mi
from 98109
Overland Park, KA
Click here to add this to my saved trials
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated:  12/31/1969
2072
mi
from 98109
Birmingham, AL
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated:  12/31/1969
2005
mi
from 98109
Lexington, KY
Metformin to Augment Strength Training Effective Response in Seniors (MASTERS)
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
2005
mi
from 98109
Lexington, KY
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
1026
mi
from 98109
Aurora, CO
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
2730
mi
from 98109
Miami, FL
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
2312
mi
from 98109
Rockville, MD
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2312
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
1775
mi
from 98109
Austin, TX
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1775
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated:  12/31/1969
8877
mi
from 98109
Kigali,
Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention
Status: Enrolling
Updated: 12/31/1969
8877
mi
from 98109
Kigali,
Click here to add this to my saved trials
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated:  12/31/1969
2485
mi
from 98109
Boston, MA
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital, One Bowdoin Square
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated:  12/31/1969
2484
mi
from 98109
Charlestown, MA
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure Naps
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital-East, Building 149
2484
mi
from 98109
Charlestown, MA
Click here to add this to my saved trials
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
Status: Enrolling
Updated:  12/31/1969
1819
mi
from 98109
Kalamazoo, MI
Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1819
mi
from 98109
Kalamazoo, MI
Click here to add this to my saved trials
N-acetylcysteine Effects on Tetrahydrocannabinol
Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol
Status: Enrolling
Updated:  12/31/1969
2432
mi
from 98109
West Haven, CT
N-acetylcysteine Effects on Tetrahydrocannabinol
Effect of N-acetylcysteine on the Acute Cognitive Effects of Delta-9-Tetrahydrocannabinol
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
2432
mi
from 98109
West Haven, CT
Click here to add this to my saved trials
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children.
Status: Enrolling
Updated:  12/31/1969
1782
mi
from 98109
Little Rock, AR
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children
Pilot Study for Determination of Total Energy Expenditure and Fat Oxidation in Children.
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Nutrition Center
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence
Status: Enrolling
Updated:  12/31/1969
2422
mi
from 98109
Charleston, SC
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Energetics and Function in Older Humans
Energetics and Function in Older Humans
Status: Enrolling
Updated:  12/31/1969
1892
mi
from 98109
Houston, TX
Energetics and Function in Older Humans
Energetics and Function in Older Humans
Status: Enrolling
Updated: 12/31/1969
Baylor Metabolic Research Unit (MRU)
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Status: Enrolling
Updated:  12/31/1969
2452
mi
from 98109
Gainesville, FL
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Status: Enrolling
Updated: 12/31/1969
University of Florida Food Science & Human Nutrition Dept
2452
mi
from 98109
Gainesville, FL
Click here to add this to my saved trials
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: A Prospective Controlled Study
Status: Enrolling
Updated:  12/31/1969
1971
mi
from 98109
Nashville, TN
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic
Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: A Prospective Controlled Study
Status: Enrolling
Updated: 12/31/1969
TVHS Nashville Campus
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Status: Enrolling
Updated:  12/31/1969
2331
mi
from 98109
Baltimore, MD
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Status: Enrolling
Updated: 12/31/1969
National Institute of Aging, Clinical Research Unit
2331
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants
Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
1617
mi
from 98109
Madison, WI
A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants
Evaluation of the Impact of Increased Gastric pH Following Omeprazole Administration on the Pharmacokinetics of Evacetrapib in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Madison
1617
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
Status: Enrolling
Updated:  12/31/1969
2371
mi
from 98109
Philadelphia, PA
Study of Radiotracer [18F]Fluortriopride ([18F]FTP) by PET/CT
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluotriopride ([18F]FTP) by PET/CT
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Study of LY2409021 Formulations in Healthy Participants
A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets
Status: Enrolling
Updated:  12/31/1969
2528
mi
from 98109
Daytona Beach, FL
A Study of LY2409021 Formulations in Healthy Participants
A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets
Status: Enrolling
Updated: 12/31/1969
Covance Cru Inc
2528
mi
from 98109
Daytona Beach, FL
Click here to add this to my saved trials
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
1018
mi
from 98109
Lakewood, CO
A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment
A Single-Dose Pharmacokinetic Study of Abemaciclib (LY2835219) in Subjects With Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
1018
mi
from 98109
Lakewood, CO
Click here to add this to my saved trials